UNA SENCILLA HERRAMIENTA DIAGNOSTICA PERMITE DETECTAR NEUROPATIA PERIFERICA Y PIE DIABETICO

(especial para SIIC © Derechos reservados)
La prueba visual Neuropad es una herramienta sencilla para evaluar la disfunción sudomotora y la neuropatía diabética, que permite el autoexamen del paciente.
koliaki9.jpg Autor:
Chrysi Koliaki
Columnista Experto de SIIC

Institución:
University of Athens Medical School


Artículos publicados por Chrysi Koliaki
Coautores
Ioanna Kolovou* Nicholas Katsilambros** Nicholas Tentolouris*** 
MD, University of Athens Medical School, Atenas, Grecia*
Professor of Internal Medicine and Diabetes, MD, PhD, FACP, University of Athens Medical School, Atenas, Grecia**
Assistant Professor, MD, PhD, University of Athens Medical School, Atenas, Grecia***
Recepción del artículo
20 de Enero, 2010
Aprobación
11 de Febrero, 2010
Primera edición
2 de Septiembre, 2010
Segunda edición, ampliada y corregida
7 de Junio, 2021

Resumen
La neuropatía es una complicación común de la diabetes y es una causa importante de morbilidad y de pie diabético. El daño de los nervios simpáticos periféricos da como resultado una disfunción sudomotora. Recientemente se presentó la prueba visual Neuropad como una herramienta diagnóstica novedosa para evaluar la función sudomotora. Entre las ventajas de Neuropad, podemos mencionar su amplia disponibilidad, el bajo costo, y la facilidad para llevarla a cabo. Además, muestra una alta precisión en el diagnóstico de neuropatía periférica. La prueba Neuropad demostró ser adecuada para el autoexamen. Más aun, datos recientes sugieren que una respuesta anormal de Neuropad se correlaciona con la ulceración en los pies. En este artículo, ofrecemos una revisión concisa de los datos publicados respecto de la utilidad clínica de Neuropad, haciendo hincapié en la posibilidad de un autoexamen confiable con esta prueba que amplía el espectro de su aplicabilidad y permite simplificar sustancialmente el procedimiento de pesquisa, lo que posibilita su aplicación clínica generalizada.

Palabras clave
prueba visual Neuropad, neuropatía periférica diabética, pesquisa, disfunción sudomotora, autoexamen, ulceración de los pies


Artículo completo

(castellano)
Extensión:  +/-9.64 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes

Abstract
Neuropathy is a common complication of diabetes and is a major cause of morbidity and foot-related problems. Damage of the sympathetic nerves in the periphery results in sudomotor dysfunction. The visual test Neuropad has been recently introduced as a novel diagnostic tool for the assessment of sudomotor function. Advantages of Neuropad consist in its wide availability, low cost, and easiness to perform. Besides, it displays a high accuracy for the diagnosis of peripheral neuropathy. The Neuropad test has been proven to be suitable for self-exanimation. Furthermore, recent data suggest that an abnormal Neuropad response correlates with foot ulceration. In the present article, we provide a concise review of published data regarding the clinical utility of Neuropad, with emphasis on the possibility for reliable self-examination with Neuropad, which broadens the spectrum of Neuropad applicability and provides a substantial simplification of the screening procedure, allowing its widespread clinical use.

Key words
visual test Neuropad, diabetic peripheral neuropathy, screening, sudomotor dysfunction, self-examination, foot ulceration


Full text
(english)
para suscriptores/ assinantes

Clasificación en siicsalud
Artículos originales > Expertos del Mundo >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Diabetología
Relacionadas: Atención Primaria, Endocrinología y Metabolismo, Geriatría, Medicina Familiar, Medicina Interna, Neurología, Nutrición



Comprar este artículo
Extensión: 9.64 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Enviar correspondencia a:
Chrysi Koliaki, University of Athens Medical School First Department of Propaedeutic Medicine, Laiko General Hospital, 115 27, 17 Ag. Thoma Street, Atenas, Grecia
Patrocinio y reconocimiento:
No declarado.
Bibliografía del artículo


1. Dyck JB, Dyck PJ. Diabetic polyneuropathy. In: Dyck PJ, Thomas PK, eds. Diabetic neuropathy, 2nd ed. Philadelphia, PA, W.B. Saunders Company, pp. 255-278, 1999.
2. Tentolouris N. Diabetic neuropathy. In: Katsilambros N, ed. Diabetes in clinical practice: Questions and answers from case studies. Chichester: John Wiley and Sons Ltd, pp. 187-199, 2006.
3. Boulton AJM. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia 47:1343-53, 2004.
4. Vinik AI, Park TS, Stansberry KB, Pittenger GL. Diabetic neuropathies. Diabetologia 43:957-73, 2000.
5. Vinik AI, Erbas T. Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med 68:928-44, 2001.
6. American Diabetes Association. Standards of medical care in diabetes - 2006. Diabetes Care 29:S4-S42, 2006.
7. Zick R, Schäper T, Deeters U. Peripheral diabetic neuropathy [in German]. Klinikarzt 32:192-4, 2003.
8. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 26:1553-79, 2003.
9. Boulton AJM, Vinik AI, Arezzo JC et al. Diabetic neuropathies: a statement by the American Diabetes Association (Position Statement). Diabetes Care 4:956-62, 2005.
10. Quattrini C, Jeziorska M, Malik RA. Small fibre neuropathy in diabetes: clinical consequence and assessment. Int J Low Extrem Wounds 3:16-21, 2004.
11. Papanas N, Giassakis G, Papatheodorou K et al. Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study. J Diabetes Complications 21:353-8, 2007.
12. Quattrini C, Jeziorska M, Tavakoli M, Begum P, Boulton AJ, Malik RA. The Neuropad test: a visual indicator test for human diabetic neuropathy. Diabetologia 51:1046-50, 2008.
13. Tentolouris N, Achtsidis V, Marinou K, Katsilambros N. Evaluation of the self-administered indicator plaster Neuropad for the diagnosis of neuropathy in diabetes. Diabetes Care 31:236-7, 2008.
14. Low VA, Sandroni P, Fealey RD, Low PA. Detection of small-fibre neuropathy by sudomotor testing. Muscle Nerve 34:57-61, 2006.
15. Report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes Care 11:592-7, 1988.
16. Liatis S, Marinou K, Tentolouris N, Pagoni S, Katsilambros N. Usefulness of a new indicator test for the diagnosis of peripheral and autonomic neuropathy in patients with diabetes mellitus. Diabet Med 24:1375-80, 2007.
17. Singer W, Spies JM, McArthur J et al. Prospective evaluation of somatic and autonomic small fibres in selected autonomic neuropathies. Neurology 62:612-8, 2004.
18. McGill M, Molyneaux L, Spencer R, Heng LF, Yue DK. Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements. Diabetes Care 22:598-602, 1999.
19. Kamei N, Yamane K, Nakanishi S et al. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening. J Diabetes Complications 19:47-53, 2005.
20. Papanas N, Papatheodorou K, Christakidis D et al. Evaluation of a new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients. Exp Clin Endocrinol Diabetes 113:195-8, 2005.
21. Kennedy WR, Navarro X. Sympathetic sudomotor function in diabetic neuropathy. Arch Neurol 46:1182-6, 1989.
22. Hoeldtke RD, Bryner KD, Horvath GG, Phares RW, Broy LF, Hobbs GR. Redistribution of sudomotor responses is an early sign of sympathetic dysfunction in type 1 diabetes. Diabetes 50:436-43, 2001.
23. Papanas N, Papatheodorou K, Papazoglou D, Christakidis D, Monastiriotis C, Maltezos E. Reproducibility of the new indicator test for sudomotor function (Neuropad) in patients with type 2 diabetes mellitus: short communication. Exp Clin Endocrinol Diabetes 2005;113:577-81, .
24. Papanas N, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D, Maltezos E. A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes. Exp Clin Endocrinol Diabetes 116:135-8, 2008.
25. Spallone V, Morganti R, Siampli M et al. Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy. Diabet Med 26:686-92, 2009.
26. Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJ. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 21:1071-5, 1998.
27. Papanas N, Giassakis G, Papatheodorou K et al. Use of the new indicator test (Neuropad) for the assessment of the staged severity of neuropathy in type 2 diabetic patients. Exp Clin Endocrinol Diabetes 115:58-61, 2007.
28. Tentolouris N, Pagoni S, Tzonou A, Katsilambros N. Peripheral neuropathy does not invariably coexist with autonomic neuropathy in diabetes mellitus. Eur J Intern Med 12:20-7, 2001.
29. Flynn MD, O'Brien IA, Corrall RJ. The prevalence of autonomic and peripheral neuropathy in insulin-treated diabetic subjects. Diabet Med 12:310-3, 1995.
30. Bilen H, Atmaca A, Akcay G. Neuropad indicator test for diagnosis of sudomotor dysfunction in type 2 diabetes. Adv Ther 24:1020-7, 2007.
31. Tentolouris N, Voulgari C, Liatis S, Kokkinos A, Eleftheriadou I, Makrilakis K, Marinou K, Katsilambros N. The moisture status of the skin of the feet assessed by the visual test Neuropad correlates with foot ulceration in diabetes. Diabetes Care 2010.
32. Tentolouris N, Marinou K, Kokotis P, Karanti A, Diakoumopoulou E, Katsilambros N. Sudomotor dysfunction is associated with foot ulceration in diabetes. Diabet Med 26:302-305, 2009.
33. Ambrosini Nobili L, Civitelli A, Campi F, Tedeschi A, Rizzo L, Piaggesi A. Neuropad is effective as first-line screening tool for the ulcerative risk of the diabetic foot. Oral Presentation No 50. 5th International Symposium on the Diabetic Foot, 9-12 May 2007.

 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618

Copyright siicsalud © 1997-2024 ISSN siicsalud: 1667-9008